Development of Advanced Technologies for Complete Genomic and Proteomic Characterization of Quantized Human Tumor Cells
Annual rept. 15 Jun 2011-14 Jun 2012
SWEDISH EPILEPSY CENTER SEATTLE WA
Pagination or Media Count:
Through this collaborative research effort, we intend to develop quantitative tools with direct applications for patients with glioblastoma. We will pursue new strategies for genome sequencing and new technologies for the genetic analyses of cancer mechanisms, as well as methods for assessment of progression and stratification of human glioblastoma. This proposal will significantly advance genomic, proteomic and single-cell technologies, and the proposed tools will be generally applicable to all cancer-based studies to identify and quantify DNA, RNAs, proteins and cells, challenges ubiquitous to all human disease systems.
- Medicine and Medical Research